A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
An investigator-blinded, randomized, multicenter, active-controlled Phase III study for the treatment of anemia in patients with CKD on hemodialysis
Epistemonikos ID: e585e60f83cbd604dc9a60accdf177b952563ecd
First added on: Jul 01, 2024